Trials / Conditions / Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8
Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8
4 registered clinical trials studyying Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8 — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adeno NCT05041153 | M.D. Anderson Cancer Center | EARLY_Phase 1 |
| Recruiting | Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Adv NCT04660760 | Academic and Community Cancer Research United | Phase 2 |
| Active Not Recruiting | Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma NCT04523818 | M.D. Anderson Cancer Center | Phase 1 |
| Completed | Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Adenocarcinoma NCT03395847 | M.D. Anderson Cancer Center | EARLY_Phase 1 |